Patent Assignment
Reel/Frame 045034/0542
Assignment of Assignor's Interest
Recorded: 2018-01-10
Pages: 12
Assignor
TABUTEAU, HERRIOT
Executed: 2017-12-01
Assignee
ANTECIP BIOVENTURES II LLC
630 FIFTH AVENUE, SUITE 2000, NEW YORK, NEW YORK, 10111
Covered Properties
(42)
Neridronic Acid Molecular Complex for Treating Complex Regional Pain Syndrome
Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Complex Regional Pain Syndrome
Pharmaceutical Compositions Comprising Frovatriptan
Application:
62/504,105 →
Compositions and Methods for Increasing the Metabolic Lifetime of Dextromethorphan and Related Pharmacodynamic Effects
Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Complex Regional Pain Syndrome
Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Complex Regional Pain Syndrome
Methods for the Safe Administration of Imidazole or Imidazolium Compounds
Methods of Treating Pain with Compositions Comprising Rank/Rankl Antagonists and Related Compounds
Compositions and Methods for Increasing the Metabolic Lifetime of Dextromethorphan and Related Pharmacodynamic Effects
Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Complex Regional Pain Syndrome
Neridronic Acid for Treating Bone Marrow Lesions
Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Complex Regional Pain Syndrome
Application:
15/459,992 →
Publication:
US US20170182072A1
Osteoclast Inhibitors for Knee Conditions
Osteoclast Inhibitors Such as Zoledronic Acid for Low Back Pain Treatment
Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Complex Regional Pain Syndrome
Application:
15/498,251 →
Publication:
US US20170224710A1
Compositions for Administration of Zoledronic Acid or Related Compounds for Treating Low Back Pain
Osteoclast Inhibitors for Knee Conditions
Osteoclast Inhibitors for Knee Conditions
Compositions and Methods for Increasing the Metabolic Lifetime of Dextromethorphan and Related Pharmacodynamic Effects
Compositions and Methods for Increasing the Metabolic Lifetime of Dextromethorphan and Related Pharmacodynamic Effects
Neridronic Acid for Treating Complex Regional Pain Syndrome
Compositions and Methods for Increasing the Metabolic Lifetime of Dextromethorphan and Related Pharmacodynamic Effects
Bupropion as a Modulator of Drug Activity
Compositions and Methods for Increasing the Metabolic Lifetime of Dextromethorphan and Related Pharmacodynamic Effects
Bupropion as a Modulator of Drug Activity
Compositions and Methods Comprising Bupropion or Related Compounds for Sustained Delivery of Dextromethorphan
Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Complex Regional Pain Syndrome
Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Complex Regional Pain Syndrome
Neridronic Acid for Treating Complex Regional Pain Syndrome
Neridronic Acid for Treating Complex Regional Pain Syndrome
Osteoclast Inhibitors for Joint Conditions
Neridronic Acid for Treating Complex Regional Pain Syndrome
Compositions for Administration of Zoledronic Acid or Related Compounds for Treating Low Back Pain
Bupropion and Dextromethorphan for Treating Nicotine Addiction
Application:
62/576,538 →
Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Complex Regional Pain Syndrome
Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Complex Regional Pain Syndrome
Application:
15/801,028 →
Publication:
US US20180050053A1
Neridronic Acid for Treating Complex Regional Pain Syndrome
Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Complex Regional Pain Syndrome
Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Complex Regional Pain Syndrome
Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Complex Regional Pain Syndrome
Neridronic Acid for Treating Complex Regional Pain Syndrome
Compositions and Methods for Increasing the Metabolic Lifetime of Dextromethorphan and Related Pharmacodynamic Effects
Patent:
10,512,643 →
Application:
15/821,563 →
Publication:
US US20180092906A1
PCT:
PCT/US2017/024140 ↗
Related Assignments
(20)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 9, 2017
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 041532/0597 →
Assignment of Assignor's Interest
Mar 14, 2017
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 041570/0113 →
Assignment of Assignor's Interest
May 23, 2017
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 042484/0040 →
Assignment of Assignor's Interest
May 24, 2017
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 042499/0218 →
Assignment of Assignor's Interest
Jun 21, 2017
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 042774/0527 →
Assignment of Assignor's Interest
Jun 21, 2017
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 042770/0157 →
Assignment of Assignor's Interest
Jun 28, 2017
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 042853/0864 →
Assignment of Assignor's Interest
Aug 8, 2017
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 043234/0837 →
Assignment of Assignor's Interest
Aug 8, 2017
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 043234/0689 →
Assignment of Assignor's Interest
Aug 11, 2017
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 043272/0641 →
Assignment of Assignor's Interest
Aug 18, 2017
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 043334/0765 →
Assignment of Assignor's Interest
Aug 29, 2017
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 043433/0326 →
Assignment of Assignor's Interest
Sep 21, 2017
From: ANTECIP BIOVENTURES II LLC
To: AXSOME THERAPEUTICS, INC.
Reel/Frame 043657/0690 →
Assignment of Assignor's Interest
Sep 27, 2017
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 043719/0465 →
Assignment of Assignor's Interest
Dec 8, 2017
From: TABUTEAU, HERRIOT
To: AXSOME THERAPEUTICS, INC.
Reel/Frame 044343/0453 →
Assignment of Assignor's Interest
Dec 8, 2017
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 044777/0488 →
Assignment of Assignor's Interest
Jan 8, 2018
From: AXSOME THERAPEUTICS, INC.
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 044558/0440 →
Assignment of Assignor's Interest
Jan 8, 2018
From: KARPPINEN, JARO I.
To: AXSOME THERAPEUTICS, INC.
Reel/Frame 044558/0397 →
Assignment of Assignor's Interest
Jan 29, 2018
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 044759/0907 →
Security Interest
May 9, 2025
From: AXSOME THERAPEUTICS, INC.; AXSOME MALTA LTD.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 071247/0836 →